Drug interactions
Docetaxel + Sipuleucel-t
Severity: Moderate
Docetaxel and Sipuleucel-t: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T depends on a functioning patient immune system, and cytotoxic chemotherapy such as docetaxel may suppress immune cells and blunt the response to the cellular product. The clinical significance is uncertain, and the two have been used in sequence in prostate cancer.
What this interaction means in plain words
Docetaxel and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Myelosuppressive and immunosuppressive effects of docetaxel may impair the immune activation that sipuleucel-T relies on.
What to do
Where possible, avoid giving docetaxel during the leukapheresis and infusion period of sipuleucel-T and coordinate the timing between the two treatments with the oncology team. Monitor for immune response and disease progression.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Docetaxel and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Docetaxel
Frequently asked questions
Can I take Docetaxel with Sipuleucel-t?
MediHelp rates the interaction as moderate. Docetaxel and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T depends on a functioning patient immune system, and cytotoxic chemotherapy such as docetaxel may suppress immune cells and blunt the response to the cellular product. The clinical significance is uncertain, and the two have been used in sequence in prostate cancer.
How serious is the interaction between Docetaxel and Sipuleucel-t?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where possible, avoid giving docetaxel during the leukapheresis and infusion period of sipuleucel-T and coordinate the timing between the two treatments with the oncology team. Monitor for immune response and disease progression.
What other medicines interact with Docetaxel?
MediHelp also lists interactions of Docetaxel with, for example, Adenovirus types 4 and 7 live, Atazanavir, Belatacept. The full list is on the Docetaxel page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
